News & Updates

Show Multimedia Only

Original New Drug Application Approvals by US FDA (16-31 March 2026)

29 Apr 2026

New drug applications approved by US FDA as of 16-31 March 2026 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (16-31 March 2026)

29 Apr 2026

Hijab wearing tied to hair, scalp disorders

27 Apr 2026 by

A review of literature presented at AAD 2026 reveals an association between hijab wearing and unique hair and scalp disorders.

Hijab wearing tied to hair, scalp disorders

27 Apr 2026

Sedentary lifestyle, late bedtime risk factors for acne

26 Apr 2026

Acne is common among people with prolonged sedentary behaviour and late bedtime but not among those who regularly engage in physical activity, according to a study.

Sedentary lifestyle, late bedtime risk factors for acne

26 Apr 2026

Deuruxolitinib improves scalp hair regrowth in patients with severe AA

23 Apr 2026 by

Treatment with deuruxolitinib, an oral Janus kinase 1/2 inhibitor, resulted in significant hair regrowth on the scalp for 24 weeks among patients with severe alopecia areata (AA), according to the two phase III THRIVE-AA1 and -AA2 trials presented at AAD 2026.

Deuruxolitinib improves scalp hair regrowth in patients with severe AA

23 Apr 2026

Anti-TNF–experienced HS patients respond well to povorcitinib

19 Apr 2026 by

The oral JAK1 inhibitor povorcitinib elicits clinical response in the subpopulation of hidradenitis suppurativa (HS) patients who had prior treatment with anti-TNF, according to pooled 24-week data from the phase III STOP-HS trials.

Anti-TNF–experienced HS patients respond well to povorcitinib

19 Apr 2026

IBD risk high in individuals with certain allergic diseases

19 Apr 2026

Individuals with atopic dermatitis or allergic rhinitis are at increased risk of inflammatory bowel disease (IBD), as suggested in a retrospective nested case–control study.

IBD risk high in individuals with certain allergic diseases

19 Apr 2026

Cannabis may reduce risk of some skin cancers

18 Apr 2026 by

The use of cannabis appears to result in a lower incidence of basal cell carcinoma (BCC) over 10 years, but not cutaneous squamous cell carcinoma (cSCC) or malignant melanoma (MM), suggests a recent study presented at AAD 2026.

Cannabis may reduce risk of some skin cancers

18 Apr 2026

Roflumilast cream effective in Chinese patients with plaque psoriasis

18 Apr 2026 by

Once-daily application of roflumilast cream 0.3% is associated with a significantly higher rate of treatment success on the Investigator's Global Assessment (IGA) scale in Chinese patients with plaque psoriasis compared with a vehicle cream, according to the phase III DERMIS-1 and -2 studies presented at AAD 2026.

Roflumilast cream effective in Chinese patients with plaque psoriasis

18 Apr 2026

IL-23 inhibitors work best at preventing PsA development in psoriasis

17 Apr 2026 by

Patients with psoriasis appear to have the lowest risk of developing psoriatic arthritis (PsA) when they are treated with IL-23 inhibitors than with other immunomodulatory agents, according to a real-world study.

IL-23 inhibitors work best at preventing PsA development in psoriasis

17 Apr 2026

Head and neck tumours linked to increased mortality in CMM patients

17 Apr 2026

Patients with cutaneous malignant melanoma (CMM) whose tumour is located in the head and neck (HN) are at greater risk of all-cause and cancer-specific mortality than those with tumours found in the trunk, reveals a study.

Head and neck tumours linked to increased mortality in CMM patients

17 Apr 2026

News & Updates

Showing Dermatology articles

Showing

Specialty:

Original New Drug Application Approvals by US FDA (16-31 March 2026)

Original New Drug Application Approvals by US FDA (16-31 March 2026)

Hijab wearing tied to hair, scalp disorders

Hijab wearing tied to hair, scalp disorders

Sedentary lifestyle, late bedtime risk factors for acne

Sedentary lifestyle, late bedtime risk factors for acne

Deuruxolitinib improves scalp hair regrowth in patients with severe AA

Deuruxolitinib improves scalp hair regrowth in patients with severe AA

Anti-TNF–experienced HS patients respond well to povorcitinib

Anti-TNF–experienced HS patients respond well to povorcitinib

IBD risk high in individuals with certain allergic diseases

IBD risk high in individuals with certain allergic diseases

Cannabis may reduce risk of some skin cancers

Cannabis may reduce risk of some skin cancers

Roflumilast cream effective in Chinese patients with plaque psoriasis

Roflumilast cream effective in Chinese patients with plaque psoriasis

IL-23 inhibitors work best at preventing PsA development in psoriasis

IL-23 inhibitors work best at preventing PsA development in psoriasis

Head and neck tumours linked to increased mortality in CMM patients

Head and neck tumours linked to increased mortality in CMM patients